The Cooper Companies, Inc. $COO Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 3.3% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 947,755 shares of the medical device company’s stock after selling 31,942 shares during the quarter. The Manufacturers Life Insurance Company’s holdings in Cooper Companies were worth $67,764,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Root Financial Partners LLC increased its stake in shares of Cooper Companies by 104.5% in the 4th quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares in the last quarter. SJS Investment Consulting Inc. grew its holdings in Cooper Companies by 107.5% in the first quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 187 shares during the period. Cromwell Holdings LLC grew its holdings in Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after purchasing an additional 273 shares during the period. CYBER HORNET ETFs LLC purchased a new stake in shares of Cooper Companies in the second quarter valued at approximately $36,000. Finally, Physician Wealth Advisors Inc. raised its stake in shares of Cooper Companies by 4,276.9% during the 4th quarter. Physician Wealth Advisors Inc. now owns 569 shares of the medical device company’s stock worth $47,000 after buying an additional 556 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on COO. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research report on Friday, June 5th. Wall Street Zen upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Sunday, June 21st. Robert W. Baird decreased their price objective on shares of Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Finally, Weiss Ratings cut shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $81.36.

Cooper Companies Stock Performance

Shares of NASDAQ:COO opened at $73.06 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The firm has a market capitalization of $14.25 billion, a PE ratio of 61.92, a P/E/G ratio of 1.88 and a beta of 0.84. The business’s 50 day moving average price is $67.97 and its 200-day moving average price is $71.87.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 EPS for the quarter, beating the consensus estimate of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the company earned $0.96 EPS. The firm’s revenue was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.